Pre-Conference Primer*
Life Sciences IP Due Diligence 101 – Preparing Your Due Diligence Checklist and Managing the Process from Soup to Nuts

Nov 2020

Philip I. Datlow
Director and Senior Counsel II Human Pharma Patents and Intellectual Property
Boehringer Ingelheim USA Corporation (Ridgefield, CT)

Jessica Jamieson
Vice President, IP Therapeutic Head, Hematology
Takeda (Chicago, IL)

This interactive working group will provide an in-depth overview of the key aspects of a comprehensive IP due diligence investigation. In this prelude to the main event, our panel of esteemed diligence counsel will provide a fact pattern and guide attendees in the process of designing an appropriate diligence team and checklist based on the presented scenario. Attendees will receive key insights on

  • Creating a cost-effective, practical due diligence roadmap
  • Identifying and selecting the most effective team members
  • Understanding what questions to ask and when•Tackling common challenges that arise during the due diligence process

*Separate registration required